Laddar...
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...
Sparad:
| I publikationen: | Indian J Endocrinol Metab |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications & Media Pvt Ltd
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240067/ https://ncbi.nlm.nih.gov/pubmed/28217523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.196029 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|